Abstract
Identifying causal regulatory relationships between microRNAs (miRNAs) and messenger RNAs (mRNAs) is essential for understanding breast cancer progression and developing targeted therapies. Traditional methods often struggle to distinguish between mere correlation and true causation, or they face significant computational hurdles. This paper introduces a novel framework based on Invariant Causal Prediction (ICP) that treats breast cancer subtypes as distinct environments to identify robust, causal interactions. The proposed hiddenICP-Pam50 method, particularly when integrated into an ensemble, demonstrates superior performance over existing state-of-the-art tools in validating against experimental ground-truth data.
Introduction
MicroRNAs (miRNAs) function as critical regulators of gene expression, acting as "dimmer switches" that can either promote tumor growth as oncogenes or inhibit it as tumor suppressors. Mapping the regulatory network between miRNAs and their target mRNAs is a central challenge in oncology. However, two primary obstacles persist: the difficulty of distinguishing correlation from causation and the high computational cost of inferring large-scale causal networks from limited sample sizes.
Methodology
The researchers developed a pipeline centered on the principle of Invariant Causal Prediction (ICP). The fundamental hypothesis is that a true causal relationship remains stable (invariant) across different biological contexts or "environments."
Environment Stratification and hiddenICP
The study utilized the Pam50 method to categorize breast cancer samples from The Cancer Genome Atlas (TCGA) into five subtypes: Basal, Her2, LumA, LumB, and Normal-like. These subtypes served as the distinct environments for the ICP algorithm. To address unobserved factors—such as transcription factors that might influence both miRNA and mRNA levels—the authors employed hiddenICP, an extension of the algorithm designed to account for hidden variables.
Ensemble Learning
To further enhance accuracy, the causal findings were combined with results from traditional statistical methods, including Pearson correlation and Lasso regression. An ensemble approach using a Borda election method was implemented to aggregate these "votes" and identify the most probable regulatory pairs.
Data Sources
The framework was trained and validated using high-quality genomic datasets:
- TCGA BRCA: Expression profiles from 503 breast cancer samples.
- Transfection Data (GEO): Experimental data involving miRNA introduction into cells, providing a "ground truth" for validation.
- Validated Databases: Results were cross-referenced with experimentally confirmed interactions from miRTarbase, TarBase, and miRWalk.
Key Results
The hiddenICP-Pam50 method consistently outperformed other causal discovery methods, such as idaFast and jointIDA, when evaluated against experimental transfection data. The results highlight the effectiveness of treating cancer subtypes as experimental environments to filter out non-causal correlations.
Furthermore, the ensemble method proved to be the most robust, suggesting that causal inference and traditional correlation provide complementary insights. Functional enrichment analysis of the identified targets revealed their involvement in critical pathways like Rap1 signaling and cell fate specification, both of which are known to drive breast cancer progression.
Discussion and Limitations
While the ICP-based approach offers a significant advancement in regulatory network inference, several limitations remain. The current model assumes linear relationships, which may not capture the full complexity of non-linear biological systems. Additionally, the requirement for sufficient sample sizes within each "environment" may limit the application of this method to rarer cancer types. Future work will focus on incorporating non-linear models and validating novel interactions through direct wet-lab experiments.
Summary updated